Resiliva 80 mg (Resmetirom) Rx

Resiliva 80 mg (Resmetirom) for treatment of NASH worldwide marketed by Onco Solution

Resiliva 80 mg (Resmetirom) Rx

Product ID: 12939

Introduction

Resiliva 80 mg (Resmetirom) is a new class of medication indicated in adult patients with noncirrhotic, nonalcoholic steatohepatitis (NASH) with moderate or advanced fibrosis. NASH is a serious, chronic liver disease marked by excessive fat deposition and inflammation that can lead to liver scarring and serious complications, including cirrhosis, and liver failure if not managed.

Resiliva is manufactured by Everest Pharmaceuticals Ltd., and offers a scientifically proven solution to enhance liver health, manage fibrosis, and lessen the severity of NASH, a metabolic disease associated with several health conditions, including obesity, type 2 diabetes, and port metabolic syndrome. Resiliva 80 mg reaches the patients, providing a better disease-free life with better health outcomes and quality of life through Onco Solution, a trusted global supplier.

Resiliva 80 mg (Resmetirom) Overview

Resiliva is an investigational medicine designed to address the underlying drivers of the disease in patients diagnosed with NASH. Its novel formulation utilizes a selective thyroid hormone receptor agonist, allowing it to intervene directly at the disease’s underlying mechanisms. This is why Resiliva is a must-have treatment option in NASH:

  • Improves Liver Health: Resiliva has been shown in clinical trials to improve liver fibrosis by a stage or more without increasing the activity of NASH.
  • NASH Symptoms are Resolved: The drug also reduces inflammation and resolves NASH symptoms, halting the progression of fibrosis.
  • Minimize Risk Factors: Resiliva markedly lowers hepatic fat content, elevated liver enzyme levels, and biomarkers of fibrosis, which ensure a holistic treatment approach.
  • The introduction of Resiliva 80 mg, with its novel mechanism of action and long-term safety profile, is a major milestone in the management of NASH.

Dosage Instructions

  • It is very important to take the recommended dosage to get the best results:
  • In patients weighing less than 100 kg: 80 mg orally once daily.
  • For patients greater than 100 kg: Administer 100 mg orally once daily.
  • Resiliva is administered either with or without food, thus offering flexibility to patients. Always listen to your health care provider for a personalized approach to your health.
  • Three Pivotal Advantages of Resiliva 80 mg (Resmetirom)
  • Resiliva provides numerous compelling benefits that make it an ideal therapy for the management of NASH:
  • From Underlying Causes to Cure of NASH: Resiliva targets the root cause of the disease leading to durable resolution and recovery.
  • Enhances Liver Function: Resiliva minimizes liver fat and inflammation thereby promoting liver function and slowing down the progression of disease.
  • Manufactured to High Standards: Resiliva is manufactured under stringent quality control conditions and at the high tech manufacturing plant of Everest Pharmaceuticals Ltd.
  • Onco Solution hasifi the supplier of Resiliva. Hope the patients can use Resiliva in the whole world tobeatisfing their needs.

Global Availability

Resiliva 80 mg is one such drug subset and Onco Solution is one of the most trusted global suppliers of oncology and specialty medicines. As a customer-oriented research group, they ensure that Resiliva’s access is granted to patients and healthcare providers in multiple countries through their strict adherence with international trade regulations.

  • Resiliva is made using innovative technology by Everest Pharmaceuticals Ltd, focused on Quality, Safety & Efficacy. Strategies like this give patients a product that stands up to the highest pharmaceutical standards, in whatever corner of the world they might be.
  • Spend in Resiliva 80 mg (Resmetirom)
  • Resiliva offered by Onco Solution is very quick and easy to access. These are the steps to complete your order:
  • Inquiry:Provide Order uplink with valid patient details and required quantities.
  • Confirmation: Get a detailed confirmation on product pricing, availability, and shipment timelines.
  • Buy: The final stage is to buy the product.
  • The efficient ordering process of Onco Solution guarantees timely deliveries, allowing healthcare providers to focus on patient care.

Why Choose Onco Solution?

  • A reliable provider is of the utmost importance in securing access to vital pharmaceuticals such as Resiliva. What sets Onco Solution apart is its dedication to quality and customer satisfaction:
  • Genuine Products: Onco Solution partners directly with manufacturers such as Everest Pharmaceuticals Ltd., guaranteeing the authenticity and quality of all products provided.
  • Transportation: Onco Solution timely and securely transported medicines to the healthcare providers and patients around the world through its well-developed global supply chain.
  • Outstanding Client Support: Onco Solution’s support staff works for you 24/7, answering questions, resolving problems, and ensuring your experience is seamless.

Comprehensive NASH Treatment

Nonalcoholic steatohepatitis (NASH) is a multifaceted problem that must be managed with the use of experts. Resiliva 80 mg (Resmetirom) focuses on reducing the visible symptoms of NASH, but also targets a molecular mechanism in the body that stops the progression of this disease. Its clinical trial data has shown efficacy in reducing fibrosis, liver fat and key biomarkers associated with NASH, which presents an opportunity for millions of patients suffering from this complex disease.

Conclusion

Approval of Resiliva 80 mg (Resmetirom) in the treatment of NASH is big news. With Everest Pharmaceuticals Ltd. ensuring the high-quality manufacturing of Resiliva and Onco Solution distributing it globally, Resiliva is changing the quality of life for patients suffering from complications of the liver.

Resiliva can help patients achieve a better quality of life and liver health by effectively alleviating symptoms and reducing the risk of long-term complications.

Related Products:

Contact Us

error: Content is protected !!
Resiliva 80 mg (Resmetirom) for treatment of NASH worldwide marketed by Onco Solution

Request quote Now